NYC Healthcare News

DiaGenic ASA announces subsequent offering of 60,000,000 shares

January 01, 2016

Letters of notification of new shares allocated and the corresponding subscription amount to be paid by each subscriber are expected to be distributed on 23 November 2010. Payment for the allocated shares falls due on 26 November 2010 in accordance with the payment procedures described in the prospectus.

The new shares may not be transferred or traded before they are fully paid and the share capital increase pertaining to the subsequent offering has been registered with the Norwegian Register of Business Enterprises. It is expected that the share capital increase will be registered in the Norwegian Register of Business Enterprises on or about 6 December 2010 and that the new shares will be admitted to trading on the Oslo Stock Exchange on the same day.

Through the subsequent offering, DiaGenic will receive proceeds of NOK 30,000,000 before the deduction of transaction costs. Following registration of the share capital increase in the Norwegian Register of Business Enterprises, the Company's share capital will be NOK 13,511,826 divided into 270,236,520 shares, each with a nominal value of NOK 0.05.

DnB NOR Markets acted as manager in the subsequent offering.

Source: DiaGenic ASA